Business Wire

BEIJING-ZHENWEI

30.3.2016 09:02:01 CEST | Business Wire | Press release

Share
Beijing International Import Food Expo 2016 to Be Held This May

The 5th Beijing International Import Food Expo 2016 (cipfe 2016) will take place on 6th -8th May, 2016 at Beijing Exhibition Center. With an exhibition area of 20,000m2 , cipfe 2016 will present 10 pavilions covering leisure food (chocolates, candies, nuts and etc), coffee and tea, beverage, organic food, wines and beers, dairy, oil, meat, etc. Over 600 international food enterprises from more than 30 countries and regions are expected to attend the exhibition, including US, Italy, Spain, Australia, Thailand, South Korea and Malaysia.

Under the theme of “Share the Global Taste”, the organizers of the event, China Chamber of International Commerce (CCOIC) and Zhenwei Exhibition Group, will provide the biggest national-level imported food trade platform for over 32,000 visitors, including import-export traders, food distributors, supermarkets, hotels, restaurants, top clubs and other related industry sectors. As one of the highlights in the exhibition, numerous buyers will also seek potential consumers and enlarge their business cooperation in Asian market.

In order to attract the most influential targeted visitors during the three-day event, the diamond buyers invitation group of cipfe 2016 will identify valuable buyers and establish and maintain contact with them, so that the exhibitors can learn the latest ideas and thoughts of the attendees. Meanwhile, some seminars such as Products Promotion Seminar, Oversea Products Purchasing Seminar and World Delicacy Tasting Seminar will be concurrently held during the exhibition.

Besides, over 100 mainstream media like People’s Daily, CCTV, Xinhua, China Daily, Beijing TV Station, sina.com.cn, ifeng.com, sohu.com, China Taiwan and Asia Food will attend the event and offer the latest industry information and investment opportunities for visitors and buyers worldwide. Furthermore, Business Recruitment Agency Conference, World Food Tasting Conference and Networking of Shop, Supermarket and E-commerce will also create great chances for both traders and buyers to learn the development trend of the food industry and make long-term win-win collaborations.

More information about cipfe 2016, please visit: www.cipfe.com .

About cipfe

Beijing International Import Food Expo (cipfe) is the only one National-level import food expo in Beijing. The CCOIC and Zhenwei will build a famous Brand Exhibition Project, and make full use of the 200,000 professional database, which include the international buyers in China, Food agencies, Supermarket, High-end club etc.

Contact:

Beijing Zhenwei Exhibition Co., Ltd.
Margaret Duan or Cassidy Liu, +8613910314389, +86-10-58236512
cipfe@zhenweiexpo.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 09:00:00 CEST | Press release

Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the

Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland11.5.2026 09:00:00 CEST | Press release

Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work. The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and s

Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 09:00:00 CEST | Press release

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic

Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 08:00:00 CEST | Press release

The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled

Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 02:30:00 CEST | Press release

India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye